Thermo Fisher

Waltham, Massachusetts-based Thermo Fisher Scientific is acquiring Qiagen N.V., based in Venlo, The Netherlands. Thermo Fisher is offering 39 euros per share in cash for a transaction total of about $11.5 billion, and is also taking on $1.4 billion of net debt.

The Trump administration secured commitments from top pharmaceutical companies to work together to develop a vaccine and treatments to fight the coronavirus.

The U.S. Department of Health and Human Services is investigating a manufacturing defect in some initial coronavirus test kits that prompted some states to seek emergency approval to use their own test kits.

Novacyt plans to launch a certified test for the coronavirus, sending the biotechnology company’s London-listed shares to a record high.

Novacyt applied for emergency approval from the U.S. Food and Drug Administration as the biotechnology company races to roll out a product that tests for the coronavirus.

At least 16 people had close contact with a Washington state man diagnosed as the first U.S. case of the coronavirus and are being monitored for the illness that has killed 17 people in China and sickened hundreds more, local officials said.

At the JP Morgan Healthcare Conference in San Francisco, Illumina CEO Francis deSouza announced a 15-year non-exclusive deal with Roche to increase the availability of next-generation sequencing-based in vitro diagnostic tests on Illumina’s diagnostic sequencing systems.

In the halls of MD Anderson Cancer Center, Vitrakvi is known for having a “Lazarus effect” in some patients because the drug can reverse late-stage cancer that has defied all other treatment options.

Essenlix Corporation announced the development of the world’s smallest, simplest, and lowest-cost blood count device – iMOST-CBC (instant mobile self-test for complete blood count).

Insulin-dependent patients with T2D saw a significant drop in blood sugar levels after wearing Abbott’s continuous glucose monitoring system compared with those who use routine fingerstick testing.